Hematopoietic Stem Cell TransplantationTransplantation, AutologousStem Cell TransplantationTransplantation, HomologousTransplantation ConditioningPeripheral Blood Stem Cell TransplantationHematopoietic Stem CellsStem CellsTreatment OutcomeGraft vs Host DiseaseMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsMelphalanHematologic NeoplasmsBone Marrow TransplantationCombined Modality TherapyKidney TransplantationRetrospective StudiesRemission InductionSalvage TherapyGraft SurvivalRecurrenceHistocompatibility TestingTissue DonorsDisease-Free SurvivalTransplantationFollow-Up StudiesHodgkin DiseaseTime FactorsCyclophosphamideHematopoietic Stem Cell MobilizationEtoposideMyeloablative AgonistsImmunosuppressive AgentsLymphoma, Non-HodgkinSurvival RateAntigens, CD34CytarabineCarmustineStem Cell NicheSurvival AnalysisBone Marrow PurgingWhole-Body IrradiationTransplantation ChimeraThiotepaVincristineBusulfanCell DifferentiationImmunocompromised HostAdult Stem CellsHematopoiesisAmyloidosisHepatic Veno-Occlusive DiseasePrognosisLymphoma, Mantle-CellEmbryonic Stem CellsMesenchymal Stem Cell TransplantationGraft RejectionBoronic AcidsLiver TransplantationPyrazinesDexamethasoneDoxorubicinLeukemiaAntibodies, Monoclonal, Murine-DerivedLymphoma, FollicularAntineoplastic AgentsThalidomideAntineoplastic Agents, AlkylatingLymphoma, T-Cell, PeripheralGranulocyte Colony-Stimulating FactorBone MarrowAutograftsCord Blood Stem Cell TransplantationProspective StudiesBone Marrow CellsCell LineageLymphomaIfosfamideLeukapheresisFlow CytometryLeukemia, Myeloid, AcuteHLA AntigensPluripotent Stem CellsInduction ChemotherapyMice, Inbred C57BLPrednisoneAnemia, AplasticCell TransplantationCytomegalovirus InfectionsHistocompatibilityPancytopeniaAcute DiseaseCells, CulturedPodophyllotoxinNeoplasm, ResidualHeart TransplantationLymphoma, Large B-Cell, DiffuseMyelodysplastic SyndromesMaintenance Chemotherapy